Jefferies Downgrades Medpace Holdings to Hold, Raises Price Target to $515

Benzinga Newsdesk www.benzinga.com Negative 80.9%

Neg 80.9% Neu 0% Pos 0%

Jefferies analyst David Windley downgrades Medpace Holdings (NASDAQ:MEDP) from Buy to Hold and raises the price target from $490 to $515.